ISRCTN16424014进行中（未招募）3 期
A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer
适应症
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 入组人数
- 183
研究概览
简要总结
2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36452431/ (added 29/12/2022)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Histologically confirmed oropharyngeal squamous cell carcinoma
- •2. HPV positive TNM8: T1-2 N1-2 (excluding T1-2 with a single ipsilateral node < 3cm), T3-4 N0-2
- •3. HPV negative TNM 8: T1N2, T2N1-N2, T3-4N0-2
- •4. Local MDT decision for concurrent chemoradiotherapy with bilateral neck treatment
- •5. Age > = 18 years
- •6. WHO performance status 0-1
- •7. Adequate renal function, glomerular filtration rate (GFR) > 60ml/min calculated using Cockcroft-Gault formula
- •8. Adequate cognitive ability (in the opinion of the local PI) to complete PRO assessments
- •9. Willingness to comply with the protocol, including travel to the proton centre for IMPT treatment
- •10. Written informed consent
排除标准
- •1. Feeding tube insertion required for nutrition due to dysphagia prior to treatment [Note: patients who have prophylactic feeding tube insertion, with or without tube use to top up nutrition prior to starting treatment, remain eligible for the study]
- •2. N3 disease
- •3. Upfront neck dissection
- •4. Use of induction chemotherapy
- •5. Previous head and neck radiotherapy
- •6. Major surgery within 6 months of trial entry
- •7. Permanent pacemaker or implantable cardioverter-defibrillator
- •8. Any invasive malignancy within previous 2 years (other than non-melanomatous skin carcinoma or cervical carcinoma in situ)
- •9. Previous or concurrent illness (e.g., active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, active peptic ulcer disease or gastritis), which in the investigator’s opinion would interfere with completion of therapy, trial assessments or follow up
- •10. Pregnancy; lactating women or women of childbearing potential unwilling or unable to use adequate non-hormonal contraception (male patients should also use contraception if sexually active)
- •11. Pre-existing speech or swallowing problems unrelated to the diagnosis of cancer
- •For patients taking part in the optional DW-MRI study at The Christie Hospital the following additional exclusion criteria apply:
- •1. Any contraindication to MRI scanning, including metallic heart valve replacement, permanent pacemaker, implantable cardiac defibrillator, non-MRI compatible metal implants, neuro-stimulators
- •2. A history of allergy/reaction to Gadolinium contrast
研究者
相似试验
进行中（未招募）
3 期
Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal CancerNCT01893307M.D. Anderson Cancer Center440
进行中（未招募）
3 期
Evaluation of a new and simple diagnostic test for malariaMalaria (uncomplicated Plasmodium falciparum malaria)Infections and InfestationsISRCTN13334317Academic Medical Center4,541
进行中（未招募）
3 期
Renal Adjuvant Multiple Arm Randomised Trial (RAMPART)Resected primary renal cell carcinomaMalignant neoplasm of kidney, except renal pelvisCancerISRCTN53348826niversity College London1,750
已完成
2 期
Study with intensity modulated radiation therapy with cisplatin to treat stage I-IVA cervical cancerCancerISRCTN54531450niversity of California, San Diego425
已完成
2 期
A clinical trial looking at the efficacy and optimal dose of acetic acid in burn wound infectionsISRCTN11636684niversity Hospitals Birmingham NHS Foundation Trust22